Ausgabe 4/2002
Inhalt (9 Artikel)
Structure of the human histamine H3 receptor gene (HRH3) and identification of naturally occurring variations
P. Wiedemann, H. Bönisch, F. Oerters, M. Brüss
Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice
P. Tutka, J. Łuszczki, Z. Kleinrok, K. Arent, M. Wielosz
The anti-parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells
W. Maruyama, T. Takahashi, M. Youdim, M. Naoi
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by l-dopa
E. R. Brunt, D. J. Brooks, A. D. Korczyn, J.-L. Montastruc, F. Stocchi
Association analysis for genetic variants of the NMDA receptor 2b subunit (GRIN2B) and Parkinson's disease
S.-J. Tsai, H.-C. Liu, T.-Y. Liu, C.-Y. Cheng, C.-J. Hong
Steele-Richardson-Olszewski-Syndrome: the relation of dopamine D2 receptor binding and subcortical lesions in MRI
G. Arnold, J. Schwarz, K. Tatsch, E. Kraft, T. Wächter, O. Bandmann, W. H. Oertel
Association of a polymorphism of the serotonin 1B receptor gene and alcohol dependence with inactive aldehyde dehydrogenase-2
Y. Hasegawa, S. Higuchi, S. Matsushita, H. Miyaoka
Rapid Communication
Alzheimer's vaccine: a cure as dangerous as the disease?
G. Münch, S. R. Robinson